Latest AI and machine learning research in genetics for healthcare professionals.
RNA has the potential to serve as a drug target, requiring RNA-small molecule binding affinity to sc...
Addressing the challenge of achieving a global circular bioeconomy requires efficient and robust bio...
PURPOSEÂ OF REVIEW: This review explores the transformative potential of artificial intelligence (AI)...
Machine learning techniques offer promising avenues for enhancing animal breeding programs by levera...
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a prevalent inflammatory disease where immunomo...
Prime editing (PE) is a precise tool for introducing genetic mutations in eukaryotes. Extending the ...
Age-related hearing loss (ARHL) is one of the most common health conditions among the elderly popula...
The black-box nature of deep learning has increasingly drawn attention to the reliability and uncert...
Polygenic scores, which estimate an individual's genetic propensity for a disease or trait, have the...
Endometrial adenocarcinoma carries a bleak prognosis, and the molecular markers that evaluate the pr...
Forensic DNA analysis has transformed criminal investigations since its inception in 1985. Over four...
The human X chromosome contains hundreds of genes and has well-established impacts on sex difference...
Colorectal cancer (CRC) is the third most common malignancy and the second leading cause of cancer-r...
Enhancers are essential non-coding DNA elements that regulate gene expression, yet their accurate id...
Recent advances in molecular dynamics (MD) simulations and the introduction of artificial intelligen...
PURPOSE: Lymph node metastasis (LNM) significantly affects prognosis and treatment strategies in non...
Thyroid cancer is the most common endocrine malignancy, with papillary thyroid cancer (PTC) account...
Breast cancer (BC) is still the most diagnosed cancer for females with an increased focus on immunot...
Regulated cell death (RCD) is crucial for the advancement of cancers, and providing opportunities as...
Breast cancer (BC) is a heterogeneous disease with diverse subtypes that influence prognosis and tre...
BCR::ABL1-targeting tyrosine kinase inhibitors (TKIs) dominate the treatment of chronic myeloid leuk...